drugset / Trial / NCT04664738
PEP on a Skin Graft Donor Site Wound
Non-randomizedSequentialSingle-blindTreatment
Summary
The purpose of this study is to determine the safety of a biological therapeutic PEP in participants who have skin graft donor site wounds.
Timeline
- Start
- 2021-03-16
- Primary completion
- 2023-08-09
- Completion
- 2024-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fibrinogen Concentrate Human | Protein / enzyme biologic | — | — |
| Subject | PEP | Other / unclassified | 10 % | — |
| Subject | PEP | Other / unclassified | 20 % | — |
Indications
No indication recorded.